{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:48:11Z","timestamp":1785552491578,"version":"3.56.0"},"reference-count":78,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2022,5,17]]},"DOI":"10.1167\/tvst.11.5.18","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T16:48:20Z","timestamp":1652806100000},"page":"18","source":"Crossref","is-referenced-by-count":14,"title":["Characterization and Validation of In Vitro and In Vivo Models to Investigate TNF-\u03b1-Induced Inflammation in Retinal Diseases"],"prefix":"10.1167","volume":"11","author":[{"given":"Carina M.","family":"Weigelt","sequence":"first","affiliation":[{"name":"Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Zippel","sequence":"additional","affiliation":[{"name":"Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Kaisa","family":"Rimpel\u00e4","sequence":"additional","affiliation":[{"name":"Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Sch\u00f6nberger","sequence":"additional","affiliation":[{"name":"Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Stierstorfer","sequence":"additional","affiliation":[{"name":"Nonclinical Drug Safety, Boehringer Ingelheim Pharma GmbH & Co.KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remko A.","family":"Bakker","sequence":"additional","affiliation":[{"name":"Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert H.","family":"Redemann","sequence":"additional","affiliation":[{"name":"Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.v214:2","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-a) in autoimmune disease and current TNF-a inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"bib3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.5114\/aoms.2014.47827","article-title":"Tumor necrosis factor inhibitors\u2014state of knowledge","volume":"10","author":"Lis","year":"2014","journal-title":"Arch Med Sci"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000055677","article-title":"Aqueous humor and serum tumor necrosis factor-a in clinical uveitis","volume":"33","author":"Lacomba","year":"2001","journal-title":"Ophthalmic Res"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","article-title":"Intraocular cytokine environment in active Beh\u00e7et uveitis","volume":"142","author":"Ahn","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/eye.2015.269","article-title":"Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up","volume":"30","author":"Groen","year":"2016","journal-title":"Eye"},{"issue":"10050","key":"bib8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1189\/jlb.0207114","article-title":"Microglia activation in retinal degeneration","volume":"81","author":"Langmann","year":"2007","journal-title":"J Leukocyte Biol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","article-title":"Inflammation and its role in age-related macular degeneration","volume":"73","author":"Kauppinen","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/ijms19040942","article-title":"Role of inflammation in diabetic retinopathy","volume":"19","author":"R\u00fcbsam","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"bib13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2478\/v10153-010-0036-8","article-title":"Serum inflammatory cytokines IL-1\u00df, IL-6, TNF-a and VEGF have influence on the development of diabetic retinopathy","volume":"53","author":"Koleva-Georgieva","year":"2011","journal-title":"Folia Medica"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jdiacomp.2007.03.001","article-title":"TNF-a is an independent serum marker for proliferative retinopathy in type 1 diabetic patients","volume":"22","author":"Gustavsson","year":"2008","journal-title":"J Diabetes Complicat"},{"issue":"2","key":"bib15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.61.2.26","article-title":"Correlation of aqueous, vitreous, and plasma cytokine levels in patients with proliferative diabetic retinopathy","volume":"61","author":"Wu","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/629529","article-title":"TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy","volume":"2013","author":"Costagliola","year":"2013","journal-title":"Mediators Inflamm"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ajo.2004.09.058","article-title":"Regression of neovascular age-related macular degeneration following infliximab therapy","volume":"139","author":"Markomichelakis","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"24100","DOI":"10.1073\/pnas.1914143116","article-title":"Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration","volume":"116","author":"Voigt","year":"2019","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"bib19","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1038\/s41467-019-12780-8","article-title":"Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration","volume":"10","author":"Menon","year":"2019","journal-title":"Nat Commun"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12974-018-1288-0","article-title":"The human microglial HMC3 cell line: where do we stand? A systematic literature review","volume":"15","author":"Russo","year":"2018","journal-title":"J Neuroinflamm"},{"key":"bib21","first-page":"894","article-title":"Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina","volume":"19","author":"Fernandez-Bueno","year":"2013","journal-title":"Mol Vis"},{"issue":"1","key":"bib22","doi-asserted-by":"publisher","first-page":"14963","DOI":"10.1038\/srep14963","article-title":"NFAT isoforms play distinct roles in TNFa-induced retinal leukostasis","volume":"5","author":"Bretz","year":"2015","journal-title":"Sci Rep"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fimmu.2019.00526","article-title":"An anti-hTNF-a variable new antigen receptor format demonstrates superior in vivo preclinical efficacy to humira in a transgenic mouse autoimmune polyarthritis disease model","volume":"10","author":"Ubah","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"bib24","first-page":"1","article-title":"The hierarchy of proinflammatory cytokines in ocular inflammation","volume":"43","author":"Cunha","year":"2017","journal-title":"Curr Eye Res"},{"issue":"11","key":"bib25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.10.11.15","article-title":"AAV-mediated expression of human VEGF, TNF-a, and IL-6 induces retinal pathology in mice","volume":"10","author":"Weigelt","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"12633","DOI":"10.1523\/JNEUROSCI.2801-06.2006","article-title":"Tumor necrosis factor-a mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma","volume":"26","author":"Nakazawa","year":"2006","journal-title":"J Neurosci"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1167\/iovs.05-0299","article-title":"TNF-a-induced optic nerve degeneration and nuclear factor-?B p65","volume":"47","author":"Kitaoka","year":"2006","journal-title":"Invest Ophth Vis Sci"},{"key":"bib28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.140.5.1490","article-title":"A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens","volume":"140","author":"Caspi","year":"1988","journal-title":"J Immunol"},{"issue":"5","key":"bib29","doi-asserted-by":"publisher","first-page":"e63002","DOI":"10.1371\/journal.pone.0063002","article-title":"Assessment and in vivo scoring of murine experimental autoimmune uveoretinitis using optical coherence tomography","volume":"8","author":"Chu","year":"2013","journal-title":"Plos One"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.ymthe.2018.03.012","article-title":"Complement-mediated activation of the NLRP3 inflammasome and its inhibition by AAV-mediated delivery of CD59 in a model of uveitis","volume":"26","author":"Kumar","year":"2018","journal-title":"Mol Ther"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.preteyeres.2004.06.005","article-title":"The role of tumour necrosis factor (TNF-a) in experimental autoimmune uveoretinitis (EAU)","volume":"23","author":"Dick","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1089\/jop.2012.0238","article-title":"Comparison of acute effect of systemic versus intravitreal infliximab treatment in an experimental model of endotoxin-induced uveitis","volume":"30","author":"Yuksel","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1096\/fsb2.v34.10","article-title":"Intravitreal administration of adalimumab delays retinal degeneration in rd10 mice","volume":"34","author":"Olivares-Gonz\u00e1lez","year":"2020","journal-title":"Faseb J"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1165\/rcmb.2014-0338MA","article-title":"Modeling pulmonary disease pathways using recombinant adeno-associated virus 6.2","volume":"53","author":"Strobel","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/hgtb.2018.228","article-title":"Standardized, scalable, and timely flexible adeno-associated virus vector production using frozen high-density HEK-293 Cell Stocks and CELLdiscs","volume":"30","author":"Strobel","year":"2019","journal-title":"Hum Gene Ther Methods"},{"issue":"10","key":"bib36","doi-asserted-by":"publisher","first-page":"e7467","DOI":"10.1371\/journal.pone.0007467","article-title":"A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat M\u00fcller cells","volume":"4","author":"Klimczak","year":"2009","journal-title":"PLOS One"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms21124271","article-title":"EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration","volume":"21","author":"Shu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12974-020-02033-7","article-title":"Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration","volume":"17","author":"Little","year":"2020","journal-title":"J Neuroinflamm"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1172\/JCI31030","article-title":"Fibrosis and diseases of the eye","volume":"117","author":"Friedlander","year":"2007","journal-title":"J Clin Invest"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ejpb.2020.06.024","article-title":"PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats","volume":"154","author":"Luaces-Rodr\u00edguez","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1021\/acs.molpharmaceut.5b00849","article-title":"A mechanistic model of the intravitreal pharmacokinetics of large molecules and the pharmacodynamic suppression of ocular vascular endothelial growth factor levels by ranibizumab in patients with neovascular age-related macular degeneration","volume":"13","author":"Hutton-Smith","year":"2016","journal-title":"Mol Pharm"},{"key":"bib42","first-page":"185","article-title":"Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept","volume":"21","author":"Du","year":"2015","journal-title":"Mol Vis"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","article-title":"Intravitreal hydrogels for sustained release of therapeutic proteins","volume":"326","author":"Ilochonwu","year":"2020","journal-title":"J Control Release"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ymthe.2018.11.003","article-title":"Preclinical evaluation of ADVM-022, a novel gene therapy approach to treating wet age-related macular degeneration","volume":"27","author":"Grishanin","year":"2019","journal-title":"Mol Ther"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2","article-title":"Tumor necrosis factor-alpha: signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"5773","key":"bib46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/286611a0","article-title":"Endotoxin-induced uveitis in rats as a model for human disease","volume":"286","author":"Rosenbaum","year":"1980","journal-title":"Nature"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1084\/jem.20061864","article-title":"Spontaneous autoimmunity prevented by thymic expression of a single self-antigen","volume":"203","author":"DeVoss","year":"2006","journal-title":"J Exp Medicine"},{"key":"bib48","first-page":"2211","article-title":"Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming","volume":"37","author":"Sartani","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1006\/jaut.1998.0197","article-title":"Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis","volume":"11","author":"Dick","year":"1998","journal-title":"J Autoimmun"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1167\/iovs.02-1156","article-title":"Neutralizing tumor necrosis factor-a activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis","volume":"44","author":"Robertson","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.exer.2006.07.007","article-title":"Inhibition of TNF-a reduces laser-induced choroidal neovascularization","volume":"83","author":"Shi","year":"2006","journal-title":"Exp Eye Res"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1167\/iovs.08-3171","article-title":"Dual role of intravitreous infliximab in experimental choroidal neovascularization: effect on the expression of sulfated glycosaminoglycans","volume":"50","author":"Regatieri","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1002\/embj.1991.10.issue-13","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1073\/pnas.92.24.11294","article-title":"Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha","volume":"92","author":"Probert","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/cyto.1997.0267","article-title":"Molecular pathogenesis of interstitial pneumonitis with TNF-a transgenic mice","volume":"10","author":"Sueoka","year":"1998","journal-title":"Cytokine"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","article-title":"Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-a","volume":"81","author":"Kubota","year":"1997","journal-title":"Circ Res"},{"issue":"1","key":"bib58","doi-asserted-by":"publisher","first-page":"31912","DOI":"10.1038\/srep31912","article-title":"AAV8-mediated angiotensin-converting enzyme 2 gene delivery prevents experimental autoimmune uveitis by regulating MAPK, NF-?B and STAT3 pathways","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3389\/fimmu.2018.01713","article-title":"Aryl hydrocarbon receptor regulates apoptosis and inflammation in a murine model of experimental autoimmune uveitis","volume":"9","author":"Huang","year":"2018","journal-title":"Front Immunol"},{"key":"bib60","first-page":"47","article-title":"Ocular inflammatory effects of intravitreally-injected tumor necrosis factor","volume":"133","author":"Rosenbaum","year":"1988","journal-title":"Am J Pathol"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ymthe.2019.12.012","article-title":"Gene therapy for glaucoma by ciliary body aquaporin 1 disruption using CRISPR-Cas9","volume":"28","author":"Wu","year":"2020","journal-title":"Mol Ther"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","article-title":"Molecular mechanisms of subretinal fibrosis in age-related macular degeneration","volume":"142","author":"Ishikawa","year":"2014","journal-title":"Exp Eye Res"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ceo.v49.3","article-title":"Epiretinal membrane: a review","volume":"49","author":"Fung","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajpath.2011.09.020","article-title":"Persistent inflammation subverts thrombospondin-1\u2013induced regulation of retinal angiogenesis and is driven by CCR2 ligation","volume":"180","author":"Chen","year":"2012","journal-title":"Am J Pathol"},{"key":"bib65","first-page":"219","article-title":"Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases","volume":"88","author":"Heidenkummer","year":"1991","journal-title":"Fortschr Ophthalmol"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12348-012-0074-x","article-title":"Immunohistochemical study of epiretinal membranes in patients with uveitis","volume":"2","author":"Sheybani","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"bib67","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41598-020-59666-0","article-title":"Analysis of inflammatory mediators in the vitreous humor of eyes with pan-uveitis according to aetiological classification","volume":"10","author":"Fukunaga","year":"2020","journal-title":"Sci Rep"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fncel.2018.00242","article-title":"An overview of in vitro methods to study microglia","volume":"12","author":"Timmerman","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"bib69","doi-asserted-by":"publisher","first-page":"e0116941","DOI":"10.1371\/journal.pone.0116941","article-title":"RNA-Seq reveals a role for NFAT-signaling in human retinal microvascular endothelial cells treated with TNFa","volume":"10","author":"Savage","year":"2015","journal-title":"PLOS One"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1254\/jphs.12129SC","article-title":"Serum levels of matrix metalloproteinase (MMP) 9, a risk factor for acute coronary syndrome, are reduced independently of serum MMP-3 by anti-TNF-a antibody (Infliximab) therapy in patients with rheumatoid arthritis","volume":"120","author":"Kotani","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"bib71","first-page":"529","article-title":"Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis","volume":"24","author":"Klimiuk","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1096\/fsb2.v17.15","article-title":"MMP-2 and MMP-9 synergize in promoting choroidal neovascularization","volume":"17","author":"Lambert","year":"2003","journal-title":"Faseb J"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12974-017-0820-y","article-title":"Peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines CCL2 (MCP-1) and CXCL8 (IL-8)","volume":"14","author":"Lechner","year":"2017","journal-title":"J Neuroinflamm"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","article-title":"Retinal microglia: Just bystander or target for therapy?","volume":"45","author":"Karlstetter","year":"2015","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"bib75","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1038\/ncomms9995","article-title":"Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis","volume":"6","author":"Flach","year":"2015","journal-title":"Nat Commun"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2012.05.004","article-title":"META060 attenuates TNF-a-activated inflammation, endothelial\u2013monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-?B and AP-1 in THP-1 monocytes","volume":"223","author":"Desai","year":"2012","journal-title":"Atherosclerosis"},{"key":"bib77","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.4049\/jimmunol.143.11.3673","article-title":"Lipopolysaccharide stimulates monocyte adherence by effects on both the monocyte and the endothelial cell","volume":"143","author":"Doherty","year":"1989","journal-title":"J Immunol"},{"key":"bib78","first-page":"796","article-title":"Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions","volume":"19","author":"Zhang","year":"2013","journal-title":"Mol Vis"},{"key":"bib6"}],"container-title":["Translational Vision Science &amp; Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2778830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T11:36:31Z","timestamp":1675596991000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2778830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.11.5.18","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,17]]}}}